Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
5(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 35 (100.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_3

PCOS Treatment Using DLBS3233, Metformin, and Combination of Both

NCT01999686
completedphase_3

Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)

NCT01733459
completedphase_3

Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus

NCT01645332
completedphase_3

Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus

NCT01472614
completedphase_3

Efficacy and Safety of DLBS3233 in Prediabetic Patients

NCT01531933

Clinical Trials (5)

Showing 5 of 5 trials
NCT01999686Phase 3

PCOS Treatment Using DLBS3233, Metformin, and Combination of Both

Completed
NCT01733459Phase 3

Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)

Completed
NCT01645332Phase 3

Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus

Completed
NCT01472614Phase 3

Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus

Completed
NCT01531933Phase 3

Efficacy and Safety of DLBS3233 in Prediabetic Patients

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5